Early Access — free while we kick the tires
EdgarHawk

CELC Celcuity Inc. Insider Trading

Latest: Director Sold $3.5M of Shares · May 2026
2 filings analyzed · Latest 2026-05-06
Insider buys
0
Insider sells
2
Unique insiders
2
Direction
Net selling
May 2026
2026-05-06
medium
Dalvey David Sell
25,000 shares
$3,517,000
@ $140.68
Significance 5/10

Director Dalvey David sells 27.8% of stake for $3.5M as CELC stock rallies off deep lows, extending his selling pattern.

Director Dalvey David executed a substantial sale of nearly 28% of his holdings while the stock is trading slightly below its recent highs and has surged significantly over the past three months. This transaction extends a marked pattern—David has sold shares nine consecutive times since mid-2025, with no offsetting purchases, suggesting a deliberate reduction in his exposure to the company. Critically, the company is burning substantial cash with significant net losses in both the latest quarter and full year, raising questions about whether the director's liquidation reflects concern about the company's cash burn trajectory. While the stock's recent momentum may have provided a favorable exit window, the absence of any insider buying and the consistent selling pattern create a mixed signal about conviction in the company's turnaround prospects.

2026-05-06
low
Buller Richard E Sell
9,000 shares
$1,264,181
@ $140.46
Significance 4/10

Director Buller exercises 9,000 shares and immediately liquidates most via open-market sales at steep markups over exercise price.

Director Richard Buller exercised options to acquire 9,000 shares at $5.10, then sold 8,840 shares throughout the same trading day at prices ranging from $137 to $143—a 27-fold markup that appears driven by the timing opportunity rather than underlying conviction about the company's fundamentals. The scale of same-day exercise-and-sell (cashless or near-cashless transaction structure) is a mechanical feature of option vesting, not a reflection of directorial confidence in Celcuity's outlook. The stock has appreciated significantly over recent months and now trades slightly below its near-term high, but the company remains deeply unprofitable with substantial quarterly losses—a context that undercuts any narrative of bullish directorial sentiment. This filing meets the rule-based threshold for reporting but represents a routine option realization rather than a discretionary buy signal.

More Health Services companies

Get alerts for CELC

Add CELC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access